*Corresponding author:
Vladimir Kulchitsky, Scientific Director, Institute of Physiology, National, Academy of Sciences of Belarus, 28 Akademicheskaya Street, Minsk 220072, Belarus, Tel.: +375-17-2842458 ; Fax: +375-17-2841630, Email: vladi@fizio.bas-net.byReceived: May 23, 2018; Published: May 29, 2018
DOI: 10.26717/BJSTR.2018.04.001119
To view the Full Article Peer-reviewed Article PDF
Low efficiency of classic antitumor therapy initiates search for new ways of early diagnostics, prophylaxis and treatment of tumors. Specialists sometimes pay attention to extraordinary strategies based, for example, on the use of stem cells (SC) as specific biological agents aimed at destruction of malignant gliomas [1-3]. These technologies are the result of stem cells fundamental ability to migrate to brain tumors penetrating through blood-brain barrier [1].
Abbrevations: MiRs: MicroRNAs, SCs: Stem Cells, TNF-α: Tumor Necrosis Factor
Introduction| Stem cells and malignant glioma cells| Contradictions in the technique of stem cells implantation in brain tumors| Conclusion| Acknowledgement| References|